Dasse
Kurt Dasse, Wellesley, MA US
Patent application number | Description | Published |
---|---|---|
20110038760 | PHOTOLYTIC ARTIFICIAL LUNG - The present invention is directed to a photolytic artificial lung. The photolytic artificial lung converts water to oxygen for blood absorption, regulates pH, the removes carbon dioxide, and co-produces electrical power is disclosed. The photolytic artificial lung includes a photolytic cell where all of the chemical reactions occur. The photolytic cell disclosed herein can also be used to direct chemical reactions in organs other than the lung. Also disclosed herein is a gas sorption device for removing carbon dioxide from the system by chemical sorption. | 02-17-2011 |
20120220815 | Pump-Inflow-Cannula, A Pump-Outflow-Cannula And A Blood Managing System - The invention relates to a pump-inflow-cannula ( | 08-30-2012 |
Kurt A. Dasse, Needham, MA US
Patent application number | Description | Published |
---|---|---|
20110190683 | EXPANDABLE AND COLLAPSIBLE MEDICAL DEVICE - A catheter (or cannula) is small enough in diameter to be placed minimally invasively into the body of a patient but also can be expanded post-placement to provide a larger-diameter placed catheter that supports fluid flow at a rate higher than is possible through the pre-placement reduced-diameter catheter. The expandable catheter is constructed using one or more shape memory polymers and can include one or more stent-like sections and/or at least part of the cannula formed as folded lobes. Each of the stent-like sections is configured to enhance the flexibility of the section as compared to the other parts of the catheter and thus allow the section to accommodate tight bends and turns when inserted into the body of the patient. The folded lobes are axial folds that constitute at least one section of the cannula, and they unfold upon expansion of the catheter to create a large cross-sectional shape. | 08-04-2011 |
Olivier Dasse, Foothill Ranch, CA US
Patent application number | Description | Published |
---|---|---|
20090030074 | SYNTHESIS, POLYMORPHS, AND PHARMACEUTICAL FORMULATION OF FAAH INHIBITORS - Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. The alkylcarbamic acid aryl ester of Formula (I), KDS-4103, is a FAAH inhibitor. Described herein is a process for the preparation of the compound of Formula (I), characterization of polymorphs of the FAAH inhibitor, and their uses therof. | 01-29-2009 |
20090099240 | METHODS FOR TREATING ENERGY METABOLISM DISORDERS BY INHIBITING FATTY ACID AMIDE HYDROLASE ACTIVITY - Disclosed herein are methods for treating energy metabolism disorders by administering a composition containing a therapeutically effective amount of a fatty acid amide hydrolase inhibitor. The composition can also be administered to reduce body fat, body weight, or caloric intake. | 04-16-2009 |